Molnupiravir for the treatment of COVID-19

molnupiravir dose  The infected hamsters were treated twice daily with the vehicle or a suboptimal dose of each compound or a combination of both compounds  Double doses should not be taken to compensate for missed doses DOSE To date, no drug interactions with molnupiravir have been identified The

Molnupiravir Generic name: molnupiravir Dosage form: oral capsule Drug class: Miscellaneous antivirals  Why am I taking LAGEVRIO? LAGEVRIO contains the active ingredient molnupiravir You are being given LAGEVRIO for the treatment of coronavirus disease

Breastfeeding is not recommended during treatment and for 4 days after the last dose of molnupiravir A lactating individual may consider interrupting If you cannot swallow capsules whole, consult with a healthcare provider • Molnupiravir can be taken with or without food • What to do if you miss a dose: •